HCPCS code A9501: Teboroxime, per study dose2026 Medicare rate & RVUs in Maryland
Technetium-99m teboroxime is a diagnostic cardiac perfusion tracer reported by nuclear medicine services when furnished for myocardial imaging.
CMS doesn’t publish an office rate for A9501 in Maryland.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What A9501 covers
Technetium-99m teboroxime is an intravenously administered radioactive tracer used in myocardial perfusion imaging to evaluate blood flow to the heart muscle. Nuclear medicine departments and other services furnishing the radiopharmaceutical report it with the cardiac imaging encounter. The study may assess perfusion at rest or with stress, as clinically performed.
Medicare assigns this code carrier-priced status: CMS publishes no national payment, and the Medicare Administrative Contractor sets payment for each claim. HCPCS pricing also assigns the code to other contractor pricing, while coverage is left to the contractor’s judgment. The code represents one diagnostic study dose, not a quantity measured in milligrams or millicuries. Report the radiopharmaceutical for the dose furnished; the applicable cardiac imaging service is represented by its own procedure code.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where A9501 pays more and less in Maryland
The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.
| Payment locality | Office | Facility |
|---|---|---|
| Baltimore area, MD | Unavailable | Unavailable |
| Rest of Maryland | Unavailable | Unavailable |
| Washington, DC area | Unavailable | Unavailable |
How the A9501 rate is calculated
Each of A9501’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · A9501
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for A9501
A9501 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · A9501
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
A9501 isn’t priced in this setting.
A9501 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- A9500Tc-99m sestamibiPer study dose
- A9500 identifies technetium-99m sestamibi. Choose the code matching the radiopharmaceutical furnished, rather than treating it as interchangeable with teboroxime.
- A9502TetrofosminPer study dose
- A9502 identifies technetium-99m tetrofosmin. A9501 is specific to teboroxime.
- A9505Thallium-201Per millicurie
- A9505 identifies thallium-201, not technetium-99m teboroxime. The code follows the tracer used for the study.
A9501 billing questions
What does one unit of A9501 represent?
One unit represents a diagnostic study dose of technetium-99m teboroxime. It is not a per-millicurie unit.
How is A9501 different from A9500 or A9502?
A9501 identifies teboroxime, A9500 identifies sestamibi, and A9502 identifies tetrofosmin. These are different radiopharmaceuticals used for cardiac perfusion imaging.
Does A9501 describe the cardiac imaging procedure?
No. A9501 identifies the radiopharmaceutical dose; the cardiac imaging service is reported with its applicable procedure code.
How does Medicare determine payment and coverage?
CMS publishes no national payment for A9501. The Medicare Administrative Contractor sets payment for each claim and makes the coverage determination.
Should A9501 be reported by the service that furnished the tracer?
Report A9501 for the diagnostic teboroxime study dose furnished by the billing service. The unit represents a study dose rather than a measured activity increment.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put A9501 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist